Neuroscience News

Supported by the Big Ideas in Neuroscience program, research from the Brunet lab suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.

This week, we sit down with neuroscientist Tony Wyss-Coray to learn about how some of your organs may be aging faster than the rest of you.

Wu Tsai Neuro researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.

Stanford researchers have found that blood from newborn humans can rejuvenate learning and memory in aged mice, a discovery that could lead to new treatments for age-associated declines in mental ability.

Studies by the Wyss-Coray lab and others have shown that organ stem cells retain their regenerative capacity, but the biochemical cues that control their function change with age — causing the abandonment of tissue maintenance and repair in the elderly.

Tony Wyss-Coray recently received a 2015 NIH Director’s Pioneer Award to build a potentially game-changing tool to track the aging process in mice.

By year’s end, we may learn whether injecting old people with blood from young people can improve their memory and even reduce the symptoms of Alzheimer’s disease.

A series of experiments has produced incredible results by giving young blood to old mice. Now the findings are being tested on humans. Ian Sample meets the scientists whose research could transform our lives.

Interestingly, and on a cheerier note, one of the biggest themes programmed into the Davos agenda this January was a series of events on the new scientific developments about the brain.

A raft of rodent experiments has demonstrated that blood transfusions from a young donor reverse the effects of aging in older recipients over recent years.